Stem cell clinics in the UK: a web-based study

Sami Kamel, Kevin R Smith*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Aim: Explore the nature and extent of web-based promotion of stem cell treatments marketed by clinics in the UK. Materials & methods: Web-based analysis of clinics in the UK using predefined variables, with analysis of eligible clinics according to preset criteria of ethical relevance. Results: A majority (79%) of UK clinics were judged to be problematic. Information was found to be lacking, misleading or otherwise problematic in several respects, including a lack of information on risks of adverse effects, unjustifiably optimistic depictions of therapeutic effectiveness, and questionable presentational approaches such as the use of celebrity patient testimonials. Conclusion: In a majority of cases, commercial clinics in the UK portray stem cell therapies on their websites in ethically questionable ways.
Original languageEnglish
Pages (from-to)1029-1036
Number of pages8
JournalRegenerative Medicine
Issue number12
Early online date11 Nov 2021
Publication statusPublished - 1 Dec 2021


  • Direct-to-consumer
  • Ethics
  • Informed consent
  • Legislation
  • Marketing
  • Policy
  • Stem cells


Dive into the research topics of 'Stem cell clinics in the UK: a web-based study'. Together they form a unique fingerprint.

Cite this